Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Wondering which credit card has the best cash back rewards? Compare various options to find the card that maximizes your earnings.
28,293 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
When a CEO puts real money behind his own company’s stock, investors sit up and take notice. This article breaks down...
Kroger's margin-led growth and private-label strength are driving a re-rating away from Walmart's ad-driven model, si...
When a kulicke soffa director sold 20,000 shares for about $2 million, it prompts questions about insider intent and ...
Ford stock has surged over the past month as investors shift focus from traditional auto earnings to Ford Energy and ...
Three crypto wallets booked $24.25 million in World Cup bets before routing proceeds to one Binance address, triggeri...
When a tech titan steps into AI, markets listen. This article explains why apple just joined revolution could reshape...
iQIYI could be among the market’s biggest comeback stories as AI-driven efficiency and overseas growth reshape its gr...
As Home Depot gears up to report, investors weigh EPS targets, margin dynamics, and housing trends. This guide breaks...
A notable new stake in Kyndryl signals growing confidence from a private equity–style shop. This deep dive explains w...
A couple funded half a home, yet their ownership rests with their in-laws. Rachel Cruze explains why deeds, wills, an...
Synopsys, a leader in chip design software, trades below its 52-week high even as revenue grows, highlighting investo...